Jazz Pharmaceuticals (JAZZ) P/E (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Jazz Pharmaceuticals (JAZZ) P/E is -58.04. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Jazz Pharmaceuticals (JAZZ)
| Year | P/E | Change |
|---|---|---|
| 2026 | -58.04 | +91.65% |
| 2025 | -30.29 | -303.50% |
| 2024 | 14.88 | -42.66% |
| 2023 | 25.96 | -109.66% |
| 2022 | -268.62 | +352.79% |
| 2021 | -59.33 | -233.87% |
| 2020 | 44.32 | +208.19% |
| 2019 | 14.38 | -32.40% |
| 2018 | 21.27 | -9.94% |
| 2017 | 23.62 | +28.37% |
| 2016 | 18.40 | -41.59% |
| 2015 | 31.50 | -83.20% |
| 2014 | 187.52 | +393.89% |
| 2013 | 37.97 | +66.73% |
| 2012 | 22.77 | +6.50% |
| 2011 | 21.38 | -75.21% |
| 2010 | 86.24 | N/A |
Comparison Jazz Pharmaceuticals (JAZZ) P/E with competitors
Jazz Pharmaceuticals (JAZZ) P/E is -58.04.